▪End-LT lactate, day 1 INR, peak ALT, ICU- and hospital-length of stay, biliary and vascular complications, PNF, CCI, Clavien Dindo complications, graft/patient survival (focus on non-tumor-related graft loss). The gene discussed is GPT; the disease is neoplasm.